Phosphoethanolamine-complexed C-reactive protein: A pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum
Authors:
- 31 August 2008
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 394 (1-2) , 94-98
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The connection between C‐reactive protein and atherosclerosisAnnals of Medicine, 2008
- Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemiaProceedings of the National Academy of Sciences, 2007
- Modified low density lipoproteins differentially bind and activate the C1 complex of complementMolecular Immunology, 2007
- C‐reactive protein inhibits in vitro oxidation of low‐density lipoproteinFEBS Letters, 2006
- Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persistMolecular Immunology, 2006
- C-Reactive Protein and Annexin A5 Bind to Distinct Sites of Negatively Charged Phospholipids Present in Oxidized Low-Density LipoproteinArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive proteinBiochemical Journal, 2002
- Macrophage Foam Cell Formation with Native Low Density LipoproteinJournal of Biological Chemistry, 2002
- Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesionsBiochemical Journal, 2002
- STUDIES OF ACUTE-PHASE PROTEIN. II. LOCALIZATION OF Cx-REACTIVE PROTEIN IN HEART IN INDUCED MYOCARDIAL INFARCTION IN RABBITS*Journal of Clinical Investigation, 1963